Blood testing device for early diagnosis of cancer and treatment monitoring
Valuation cap โ
$22.0M
As of Dec 2022 ยท from Delee Crowd SAFE 3 ยท a SAFE/note conversion ceiling, not a priced valuation
Total raised
$2,647,658
Across 4 rounds since 2019
Latest share price
$1.00
Delee Crowd SAFE 3 offering price
Financials
FY2017โFY2022 ยท from SEC filings ยท hover any figure for its source
$0
โ$382K
2017
$0
โ$169K
2018
$43K
$13K
2019
$0
โ$228K
2020
$0
โ$444K
2021
$0
โ$37K
2022
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
Income statement
Revenue
$0
$0
$43,448
$0
$0
$0
Cost of goods sold
$309,441
$114,150
$1,454
$0
$0
$0
Gross margin
โ
โ
97%
โ
โ
โ
Net income
-$382,462
-$168,816
$12,563
-$227,623
-$444,284
-$37,205
Taxes paid
$0
$1,200
$1,700
$800
$0
$0
Balance sheet
Cash
$646,306
$160,873
$1,506
$342,636
$75,402
$87,049
Accounts receivable
$649,285
$163,877
$0
$0
$0
$0
Total assets
$814,285
$644,162
$659,884
$1,399,999
$253,337
$1,445,405
Short-term debt
$1,333
-$1,333
$750
$200
$76,086
$126,086
Long-term debt
$2,057
$750
$0
$0
$0
$0
Total liabilities
$3,390
-$583
$750
$200
$76,086
$126,086
Other
Headcount
โ
15
โ
22
0
3
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
A dashed amber step is a SAFE/note valuation cap โ a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.